Literature DB >> 22280465

Polypoidal choroidal vasculopathy in patients diagnosed with neovascular age-related macular degeneration in Denmark.

Tomas Ilginis, Søren Ottosen, Kristian Harbo Bundsgaard, Carl Uggerhøj Andersen, Henrik Vorum.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22280465     DOI: 10.1111/j.1755-3768.2011.02329.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  5 in total

1.  The role of indocyanine green angiography imaging in further differential diagnosis of patients with nAMD who are morphologically poor responders to ranibizumab in a real-life setting.

Authors:  A Ozkaya; C Alagoz; R Garip; Z Alkin; I Perente; A T Yazici; M Taskapili
Journal:  Eye (Lond)       Date:  2016-04-15       Impact factor: 3.775

Review 2.  The Use of Vascular Endothelial Growth Factor Inhibitors and Complementary Treatment Options in Polypoidal Choroidal Vasculopathy: A Subtype of Neovascular Age-Related Macular Degeneration.

Authors:  Kelvin Yi Chong Teo; Mark Gillies; Samantha Fraser-Bell
Journal:  Int J Mol Sci       Date:  2018-09-03       Impact factor: 5.923

Review 3.  Polypoidal choroidal vasculopathy: An update on current management and review of literature.

Authors:  Amit Harishchandra Palkar; Vikas Khetan
Journal:  Taiwan J Ophthalmol       Date:  2019 Apr-Jun

4.  Polypoidal Choroidal Vasculopathy in Congolese Patients.

Authors:  Nelly N Kabedi; David L Kayembe; Gloria M Elongo; Jean-Claude Mwanza
Journal:  J Ophthalmol       Date:  2020-01-18       Impact factor: 1.909

Review 5.  European Prevalence of Polypoidal Choroidal Vasculopathy: A Systematic Review, Meta-Analysis, and Forecasting Study.

Authors:  Elon H C van Dijk; Jeppe K Holtz; Marc J Sirks; Janni M E Larsson; Roselie M H Diederen; Reinier O Schlingemann; Camiel J F Boon; Yousif Subhi
Journal:  J Clin Med       Date:  2022-08-16       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.